跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FAMPRIDINA QUALIGEN 10 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
FAMPRIDINA QUALIGEN 10 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
FAMPRIDINA QUALIGEN 10 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Neuraxpharm Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 1, 2021
Approval ID
cf06b9e62c41ba24
Company
Neuraxpharm Spain S.L.
Type
Standard
Approval Details
Approval Id
cf06b9e62c41ba24
Drug Cima Aemps Name
FAMPRIDINA QUALIGEN 10 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
86057
Holder Company Name
Neuraxpharm Spain S.L.
Marketing Company Name
Neuraxpharm Spain S.L.
Authorization Date
2021-07-01
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Neuraxpharm Spain S.L.
Active Ingredients
FAMPRIDINA
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 1, 2021
Approval ID
cf06b9e62c41ba24
Type
Standard
Back to CIMA-AEMPS Approvals